Roche Holding AG Virtual Event on Key Hematology Data Presented at ASH 2020 Transcript
Ladies and gentlemen, welcome to the update following ASH 2020 webinar. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions) At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.
Yes. Thanks a lot, Henrik. Warm welcome from my side, 2020 ASH audio webcast for Roche. I'm here with Tom Fuchs. Maybe you could kindly go to the agenda. Perfect. Thank you. I'm here with Tom Fuchs. He's the Vice President, GPS, Hematology. So basically, this is the commercial arm of Roche. And we have Ginna Laport. She's the VP for Development, Global Head of Hematology. Marion Ott, Global Franchise Head, AML, Multiple Myeloma, Pediatric. And after the presentation, there is a Q&A session. (Operator Instructions)
Maybe you can go to the next slide here. I mean 2020 was maybe a bit different than that what we would have expected in January, February this year, I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
